Search
Search Results
##search.searchResults.foundPlural##
-
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1691Suppl. Files: 837HTML: 405PDF: 710 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1909PDF: 845HTML: 1313 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6206PDF: 2057HTML: 13977Untitled: 185figure: 167 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1918PDF: 796HTML: 2188Table 1: 160Table 2: 181Table 3: 174Table 4: 178Table 5: 174Tble 6: 168Cover Letter: 190Greene Tab.7: 171 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4160PDF: 1493HTML: 432 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3779Suppl. Files: 1060PDF: 1026Html: 113 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
1984PDF: 1833HTML: 332 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1786PDF: 697HTML: 2086Untitled: 196Untitled: 141Untitled: 157Untitled: 142Untitled: 148Untitled: 161Untitled: 171 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1638PDF: 1067HTML: 10689Untitled: 170 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4729PDF: 1725HTML: 2690Untitled: 197 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1968PDF: 1390HTML: 248 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3678PDF: 1530HTML: 8009Randi Fig: 163 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4001PDF: 1888HTML: 1749 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3967PDF: 1015HTML: 3559Untitled: 167Cneo. Fig.1: 102Untitled: 91Untitled: 117Untitled: 118 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4018PDF: 1544HTML: 858 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3452PDF: 1586HTML: 2663 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2035PDF: 971HTML: 4054Cover Letter: 208Figure 1: 211Figure 2: 217Table 1: 191 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5159PDF: 2508HTML: 30118Antinori Tables 1,2,3: 325 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2282PDF: 1553HTML: 585 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1365PDF: 480HTML: 3944 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3485PDF: 1451HTML: 4304CoverLetter: 172Figure1: 178 -
IMMUNOLOGY OF TUBERCULOSIS
5158PDF: 1969HTML: 7254Untitled: 188 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
5962PDF: 3159HTML: 8992Figure Malaria Ricci: 210 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2152PDF: 927HTML: 5027Cover Letter: 156Figure 2: 144Figure 1: 157Figure 3: 173Figure 4: 154Figure Legend: 168Table 1: 170Table 2: 164Table 3: 165 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2387PDF: 1262HTML: 1729CoverLetter: 161 -
-
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7736PDF: 4012HTML: 7300 -
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
498PDF: 268Html: 19 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3463PDF: 2356HTML: 1416 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4668PDF: 1517HTML: 2234Untitled: 195Untitled: 209Untitled: 216Untitled: 198Untitled: 200 -
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major
548PDF: 403Html: 96 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2328PDF: 1367HTML: 1961 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1468PDF: 1157HTML: 173 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2089PDF: 1389HTML: 683







